SEC Form 4 · accession 0001645627-17-000138
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 10, 2017
Accepted (ET)
Nov 15, 2017 · 11:39 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2017 | P | 3,000 | $0.0478 | A | 24,156,189 | D | |
| Common Stock | Nov 10, 2017 | P | 3,000 | $0.0496 | A | 24,159,189 | D | |
| Common Stock | Nov 10, 2017 | P | 3,000 | $0.052 | A | 24,162,189 | D | |
| Common Stock | Nov 13, 2017 | P | 3,000 | $0.048 | A | 24,165,189 | D | |
| Common Stock | Nov 13, 2017 | P | 3,000 | $0.048 | A | 24,168,189 | D | |
| Common Stock | Nov 13, 2017 | P | 3,000 | $0.048 | A | 24,171,189 | D | |
| Common Stock | Nov 13, 2017 | P | 3,000 | $0.048 | A | 24,174,189 | D | |
| Common Stock | Nov 13, 2017 | P | 3,000 | $0.0479 | A | 24,177,189 | D | |
| Common Stock | Nov 14, 2017 | P | 3,000 | $0.0474 | A | 24,180,189 | D | |
| Common Stock | Nov 14, 2017 | P | 3,000 | $0.047 | A | 24,183,189 | D | |
| Common Stock | Nov 14, 2017 | P | 3,000 | $0.046 | A | 24,186,189 | D | |
| Common Stock | Nov 14, 2017 | P | 3,000 | $0.046 | A | 24,189,189 | D |
Table II — derivative securities
No Table II lines on this filing.